The third bellwether trial in the multidistrict litigation (MDL) over the blood thinner Xarelto was scheduled to begin last week in Mississippi. The Xarelto litigation is current the third largest MDL in the U.S.
The upcoming lawsuit was filed against Janssen Pharmaceuticals and Bayer Healthcare by patient Dora Mingo, who alleges that she suffered complications from Xarelto after being prescribed the drug by her doctor. Studies have linked Xarelto to an increased risk of severe bleeding incidents or other adverse events compared with other anti-coagulant medications.
According to her lawsuit, Janssen and Bayer failed to properly warn doctors and patients about the risk of severe bleeding incidents associated with Xarelto. Mingo alleges that she developed deep vein thrombosis – a condition that caused potentially fatal blood clots to form in the legs – after undergoing hip replacement surgery in 2015. After she was prescribed Xarelto by her doctor to prevent blood clots, Mingo alleges that she developed severe gastrointestinal bleeding, which she alleges was caused by Xarelto.
Xarelto was developed as an alternative to the blood thinner warfarin – also known as Coumadin – which required extensive blood monitoring and dietary changes in order to prevent complications. Although Xarelto does not require the same level of monitoring, the drug has no known antidote that can be administered in the event of severe bleeding incidents. Because of this, patients taking Xarelto may be at risk of severe and potentially fatal bleeding incidents.
The first lawsuit involving Xarelto was filed in 2014 by a patient who suffered severe bleeding requiring hospitalization after being prescribed this medication. Since 2014, roughly 5,000 Xarelto lawsuits have been filed against Janssen and Bayer. These lawsuits have alleged that patients taking the blood thinner are at risk of gastrointestinal bleeding, spinal bleeding, hemorrhages, internal bleeding, or other complications. The lawsuits also allege that Xarelto has been linked to hundreds of deaths and thousands of other serious bleeding incidents.
Lawsuits Filed by Heygood, Orr & Pearson on Behalf of Xarelto Users
If you or a loved one have suffered gastrointestinal bleeding or other severe bleeding events caused by Xarelto, you may qualify to file a lawsuit. The first step in taking legal action is to speak with an attorney regarding your legal options and discuss the first steps in filing a claim.
The lawyers at Heygood, Orr & Pearson has filed lawsuits on behalf of patients who were injured after taking the blood thinners Pradaxa and Xarelto. Our firm has also handled numerous other pharmaceutical liability cases, including lawsuits involving the drugs Yasmin, Actos, Avandia, and Zofran. Heygood, Orr & Pearson has handled more cases involving the fentanyl pain patch than all other law firms in the country combined, and have filed numerous lawsuits on behalf of patients who were injured after taking other dangerous medications.
The law firm of Heygood, Orr & Pearson has tried hundreds of cases to verdict and have achieved settlements in hundreds more on behalf of our clients. At Heygood, Orr & Pearson, we believe that when drug companies manufacture dangerous medications or medical devices, they should be held responsible for the injuries caused by these products in a court of law.
For more information about filing a Xarelto lawsuit and to receive a free consultation to learn whether you may qualify to take legal action, contact the attorneys at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001. You can also reach us by following this link to our free case evaluation form and answering a few brief questions about your case to get started.